Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma

NCT03514069 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Glioma
Glioblastoma

Interventions

DRUG: ruxolitinib
RADIATION: radiation
DRUG: temozolomide

Sponsor

Case Comprehensive Cancer Center